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Available online 25 March 2008In recent years, yeast has been proven to be a useful model organism for studying programmed cell death. It
not only exhibits characteristic markers of apoptotic cell death when heterologous inducers of apoptosis are
expressed or when treated with apoptosis inducing drugs such as hydrogen peroxide (H2O2) or acetic acid, but
contains homologues of several components of the apoptotic machinery identiﬁed in mammals, ﬂies and
nematodes, such as caspases, apoptosis inducing factor (AIF), Omi/HtrA2 and inhibitor-of-apoptosis proteins
(IAPs). In this review, we focus on the role of negative regulators of apoptosis in yeasts. Bir1p is the only IAP
protein in Saccharomyces cerevisiae and has long been known to play a role in cell cycle progression by acting
as kinetochore and chromosomal passenger protein. Recent data established Bir1p's protective function
against programmed cell death induced by H2O2 treatment and in chronological ageing. Other factors that
have a direct or indirect inﬂuence on intracellular levels of reactive oxygen species (ROS) and thus lead to
apoptosis if they are misregulated or non-functional will be discussed.






Apoptosis is a highly regulated cellular death program that is
crucial for the development and maintenance of multicellular orga-
nisms. In the past few years, however, it became evident that apoptosis
might not only occur inmulticellular, but also in unicellular organisms,
such as the yeast Saccharomyces cerevisiae (reviewed in [1]). S. cere-
visiae shows typical apoptotic hallmarks when treated with various
agents including hydrogen peroxide and acetic acid [2–5]. Other
than the morphological characteristics, a growing list of homologues
to apoptotic regulators in metazoans has been identiﬁed [6–10]. In
addition, yeast programmed cell death has been linked to cellular
events such asmitochondrial fragmentation [11], cytochrome c release
[12], ageing [13,14] and phosphorylation of histone H2B [15]. Taken
together, these ﬁndings support the general view that a basic ma-
chinery of apoptosis is present and functional in yeast.
Apoptosis typically involves the activation of a unique class of cys-
teine proteases known as caspases [16]. These proteases bring about
apoptosis by cleaving key cellular substrates after speciﬁc aspartate
residues. Caspases are synthesized as inactive zymogens and two classes
of caspases are involved in cell death, i.e. the initiator caspases and the
effector caspases [16]. Initiator caspases can be activated by distinct
scaffolding factors, such as the apoptotic protease activating factor 1
(Apaf-1) and the apoptosome or so-called death-receptors in the plas-
ma membrane and the death-inducing signalling complex (DISC) [17].
Activated initiator caspases in turn are capable of activating effector
caspases, the ultimate executors of cell death.renkrog).
l rights reserved.Once activated, both initiator caspases and effector caspases can
be modulated by a set of proteins, known as inhibitor-of-apoptosis
proteins (IAPs). IAPs were initially identiﬁed in baculoviruses and
found to prevent apoptosis of the host cell [18]. IAP homologues have
been identiﬁed in mammalian cells, worms, ﬂies and yeast [19] and
they are characterized by the presence of one to three copies of the
baculovirus IAP repeat (BIR) domains (Fig. 1). BIR domains typically
comprise 70 to 80 residues and hold a zinc ion that is coordinated
by one conserved histidine and three cysteine residues. Via the BIR
domain, IAPs are able to bind caspases, thereby preventing the in-
teraction of caspases with their substrates [16]. Additionally, some
IAPs contain a second zinc-binding motif known as RING domain
(Fig. 1), which exhibits E3-ubiquitin-ligase activity. By such a RING
domain, IAPs recruit and direct E2-ubiquitin-conjugating enzymes to
speciﬁc substrates, such as caspases [20–22], to catalyze the transfer
of ubiquitin to the substrate, which is subsequently degraded by the
26S proteasome. Furthermore, IAPs can trigger their self-degradation
[23], thereby leading to enhanced caspase activity.
IAPs are distinguished into type-I or type-II BIR-domain-containing
proteins (BIRPs) dependingon the structure of the BIR domains and the
presence or absence of a RING domain (Fig. 1). Type-II BIRPs, such as
the Caenorhabditis elegans proteins Bir1 and Bir2, yeast Bir1p or human
survivin are known to play roles in chromosome segregation and
cytokinesis [24]. Moreover, the type-II BIRPs Bir1p [10,25–27], survivin
[28–31], Drosophila Deterin and Bruce and the murine TIAP are able to
inhibit apoptosis, unlike C. elegans Bir1 and Bir2, by a yet unknown
mechanism [32–35].
IAP-mediated inhibition of caspase activity, however, is not suf-
ﬁcient to regulate apoptosis. Hence, not only the activity but also the
activation of caspases is tightly regulated. The latter involves the release
of pro-apoptotic factors like cytochrome c from the mitochondrial
Fig. 1. Schematic representation of BIR-containing proteins. BIR containing proteins are characterized by the presence of multiple domains, such as BIR, RING, CARD, and UBC
domains. Their approximate positions are represented with the total amino acid length shown to the right of each protein. RING domains confer E3 ubiquitin protein ligase activity;
UBC refers to the ubiquitin-conjugating domain, which has E2 activity. The presence of both these domains in components of the apoptotic machinery suggests a link between
apoptosis and protein degradation. Adapted from [127]. Abbreviations: BIR: baculoviral IAP repeat; RING: RING (really interesting new gene) zinc-ﬁnger; CARD: caspase recruitment
domain; UBC: Ubiquitin-conjugating enzymes.
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apoptosome. Major regulators of mitochondrial integrity and mito-
chondrion-initiated caspase activation are proteins of the Bcl-2 family
[37,38]. BCL-2 (B-cell lymphoma 2) was initially identiﬁed as a gene
whose product causes resistance to apoptosis in lymphocytes [39,40].
Subsequent studies, however, identiﬁed a number of both pro- as well
as anti-apoptotic Bcl-2-related proteins. The Bcl-2 family is deﬁned by
homology sharedwithin four conserved regions in Bcl-2, termed BCL-2
homology (BH) domains, and is grouped into three subfamilies
depending on their apoptotic properties, i.e. the pro-apoptotic Bax-
and BH3-only families aswell as the pro-survival Bcl-2 family (Fig. 2). As
of today, no clear homologues of Bcl-2-like proteins have been
identiﬁed in yeast. However, heterologous expression of Bcl2-like
proteins in yeast indicated that members of the Bcl-2 family interfere
with the endogenous cell deathpathwayof yeast and that yeast exhibits
a responsemachinery to Bcl-2-like proteins,mediated by the conserved
Bax inhibitor 1 (BI1) protein (see section 3 for details).
In this review, we will elaborate different molecular mechanisms
as to how apoptosis is antagonized in yeast. First, we will focus on the
conserved regulator of apoptosis, Bir1p, which is the only member of
the IAP family in yeast. Next, we will discuss data suggesting that
metazoan Bcl-2 family members interfere with the apoptotic ma-
chinery in yeast. Finally we will cover other mechanisms that lead to
inhibition of apoptosis in yeast, including anti-oxidant enzymes and
other factors that have a direct or indirect inﬂuence on intracellular
ROS levels.
2. Bir1p — the inhibitor-of-apoptosis protein in yeast
S. cerevisisae BIR1 is a gene encoding a ~108 kDa protein and based
on sequence homology it appears to be the only member of the
inhibitor-of-apoptosis protein family in this organism [41]. Bir1p bears
two type-II BIR domains at its N-terminus, while lacking a RINGdomain (Figs. 1 and 3). Bir1p localizes to the nucleus of cells due to
a putative nuclear localization signal (NLS) and its C-terminal ~80
amino acids are sufﬁcient for association with the anaphase spindle
[26,42] (Fig. 3). Until recently, the role of Bir1p in cell division rather
than in apoptosis was examined intensively [25–27,42–48]. By two-
hybrid studies it was shown that Bir1p interacts with components
of the kinetochores, i.e. Ndc10p, which is a subunit of the inner
kinetochore subcomplex CBF3 [25]. Bir1p is essential for spore for-
mation and germination, but not for vegetative growth and deletion of
the BIR1 gene leads to a chromosome mis-segregation phenotype as
shown by a colony color-sectoring assay [25]. Moreover, a tandem
afﬁnity puriﬁcation (TAP) approach identiﬁed an in vivo interac-
tion of Bir1p with the homologues of human Aurora B kinase and
inner centromere protein (INCENP), Ipl1p and Sli15p, respectively
[44], pinpointing to Bir1p's roles in chromosome bi-orientation,
spindle stabilization, and cytokinesis [43,45,46,48].
In addition to the well-known role of Bir1p as a chromosomal
passenger protein, it recently became evident that Bir1p is involved in
apoptosis regulation in S. cerevisiae as well [10]. Bir1p is cleaved by the
pro-apoptotic serine protease Nma111p, when over-expressed from
an episomal plasmid, and both proteins are directly interacting in vitro
[10]. The molecular mechanism by which Bir1p exhibits its anti-
apoptotic function, however, has remained elusive, since Bir1p does
not bind the yeast caspase Yca1p [10]. Nevertheless, cells lacking BIR1
show typical hallmarks of apoptosis, such as chromatin condensation
and fragmentation, DNA single strand breaks and accumulation of
ROS, whereas over-expression of Bir1p protects cells against apoptosis
induced by H2O2 treatment or during chronological ageing. Simulta-
neous over-expression of Nma111p reverses the protective effect of
increased Bir1p levels, underlining the interaction between the two
proteins in vivo [10].
Interestingly, Bir1p has recently been shown to be SUMOylated
[49–51], which in turn is dependent on its localization to the anaphase
Fig. 2. Three subfamilies of Bcl2-related proteins. Bcl-2-related proteins are characterized by the presence of multiple copies of a Bcl-2 homology (BH) domain. Typically Bcl-2 family
members additionally have a carboxy-terminal transmembrane domain (TM), with the exception of A1 and members of the BH3-only family (Bad, Bid, Noxa, Bmf and Puma).
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modiﬁcation of Bir1p is lost in a bir1 variant lacking the BIR repeats and
upon spindle checkpoint activation by nocodazole, implying a role of
Bir1p SUMOylation in apoptosis and/or spindle checkpoint regula-
tion, respectively. Moreover, Bir1p levels have been shown to ﬂuctuate
during the cell cycle and Bir1p gets phosphorylated in a cell cycle-
dependentmanner [42]. Both, regulation of Bir1p levels and its diverse
post-translational modiﬁcations might play a role in coordinating the
different functions of the protein including its anti-apoptotic activity.
The yeast Schizosaccharomyces pombe also contains a BIR1 homo-
logue, known as PHB1 [26]. Similar to Bir1p, Phb1p acts as a
chromosomal passenger protein in anaphase, plays a role in cytokin-
esis, and has been implicated a role in recruitment of condensin to
chromosomes [26,52–55]. Although apoptotic scenarios have been
observed in ﬁssion yeast, i.e. upon heterologous expression of human
Baxor Bak [56] or impairment of triacylglycerol synthesis [57], a role of
Phb1p in apoptosis regulation, has not yet been described. Never-
theless, the expression of PHB1 is regulated by the transcription factor
Pap1p [58], the S. pombe homologue of mammalian AP-1 [59]. Pap1p
has been shown to play a role in the response to oxidative stress and a
variety of cytotoxic agents [60] and PHB1 expression is regulated by
carbon sources in a Pap1p-dependent manner [61]. This suggests that
the up-regulation of PHB1 helps ﬁssion yeast cells to survive under
poor nutrient conditions, which in turn implies that Phb1p might also
play a role in apoptosis regulation in S. pombe.
3. Heterologous expression of various proteins interferes with the
intrinsic cell death program in yeast
Yeast as unicellular organism was long supposed to lack an
apoptosis-like death program. Therefore it had been used as “clean
room” for investigating the interaction of mammalian proteins in-
volved in apoptosis, such as proteins from the Bcl-2 family. Hetero-
logous expression of Bax, a pro-apoptotic Bcl-2 family member,
results in a lethal phenotype in yeast, which can be antagonized by
co-expression of the anti-apoptotic members of the Bcl-2 family,
including Bcl-2 and Bcl-xL [56,62,63] and such studies helped to iden-
tify the domains of Bcl-2 that are relevant for suppression of apop-
tosis [64]. Moreover, Xu et al. identiﬁed BI-1 (Bax inhibitor 1), an
intracellular multi-membrane-spanning protein in S. cerevisiae, which
is conserved in mammals, plants, and fungi, as Bax antagonist [65],
indicating that yeast harbours an intrinsic response machinery to Bcl-
2-like proteins. This is further supported by the ﬁnding that yeast cells
expressing Bax show typical morphological changes that characterizeapoptosis [66], and that Bax induces the release of cytochrome c from
mitochondria [67], a hallmark of Bax action in mammalian cells. In
contrast, Kissova et al. suggested that yeast cells expressing Bax show
characteristics of autophagy rather than apoptosis [68]. However, the
expression of the human cellular prion protein (PrP) can prevent Bax-
mediated apoptosis, both in human and in yeast cells [69,70] by in-
hibiting the ﬁrst step of Bax activation, namely a conformational
change of Bax [71–73], similarly to other known Bax inhibitors in-
cluding Bcl-2. Whether yeast prion protein has a similar protective
function remains to be investigated.
In addition, heterologous expression of anti-apoptotic members of
the Bcl-2 family in yeast confers a cytoprotective effect in the absence
of Bax [74] and causes increased long-term survival [75] and enhanced
resistance to H2O2 [76]. Together these ﬁndings suggest that members
of the Bcl-2 family can interfere with a highly conserved cell death
program in yeast and higher eukaryotes.
4. Reactive oxygen species and anti-oxidants regulate apoptosis
During aerobic growth and in response to environmental stresses
such as temperature or diauxic shift, lack of nutrients, and UV damage,
cells produce ROS. Because these molecules are toxic to the cell,
an elaborate system with a variety of enzymes has evolved that is
responsible for cleaning the cell of ROS, and strict regulation of this
system is essential for normal growth (reviewed in [77]). In this
context, ROS have also been determined to be the main mediator of
programmed cell death [4]. Chronologically aged yeast cells die with
typical hallmarks of apoptosis, in particular enhanced levels of ROS,
whereas a reduction of intracellular ROS has been shown to extend
the replicative as well as the chronological lifespan [78]. The cyto-
solic and mitochondrial superoxide dismutases, Sod1p and Sod2p,
respectively, are required for reduction of ROS in the cell and for long-
term survival of yeast [79] and consistently over-expression of either
the two proteins increases the lifespan [14] underlining the protec-
tive role of the anti-oxidant system for longevity. Similarly, over-
expression of the non-essential yeast catalase CTT1, which reduces
intracellular H2O2 levels, has been shown to protect cells against
apoptosis induction by acetic acid [80].
An important factor with anti-oxidant and therefore anti-apoptotic
activity is the tripeptide glutathione [4,81]. The depletion of glu-
tathione in yeast cells leads to massive DNA fragmentation and
enhanced sensitivity towards H2O2 [4]. In accordance with this ob-
servation, levels of cytoplasmic O-acetylhomoserine sulfhydrolase, a
protein central for glutathione synthesis that is encoded byMET17, are
Fig. 3. Domain organization and localization of yeast Bir1p. (A) Schematic representation of Bir1p organization. The two N-terminal BIR type-II domains (BIR, amino acids 12–116 and
145–240), potentially SUMOylated lysine residues within consensus motives with high probability of modiﬁcation according to Abgent's SUMOplot™ Prediction (K), potential Cdc28
phosphorylation sites [42] (S, T), and the putative nuclear localization signal [26] (NLS, amino acids 386–393) are indicated. The arrows indicate known and assumed protein
interactions. (B) Immunoﬂuorescence images of Bir1p-Myc13 show its localization in the nucleus at different cell cycle stages. During G1, S and early G2/M phase Bir1-Myc13
associates with the kinetochores and relocalizes to the anaphase spindle in late G2/M (from left to right).
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anti-oxidant levels are important for regulation of ROS and that low
levels of ROS prevent the induction of programmed cell death.
Recently, a direct relation between actin dynamics, ROS production
and apoptosis has been demonstrated (reviewed in [83]). Actin-
stabilizing drugs or mutations have been shown to lead to an increase
of ROS and decreased cell viability, whereas destabilization of the
actin cytoskeleton by deletion of SCP1 encoding for an actin-bundling
protein causes a decrease in ROS and an increase in lifespan [84].
These observations indicate the importance of maintaining the dy-
namic stage of the actin cytoskeleton for the regulation of ROS levels
and the prevention of programmed cell death.
The response to environmental stresses leads to an increased
amount of ROS in yeast cells. Several proteins have been shown to
protect against programmed cell death by regulating the stress
response. SVF1 is a gene that was identiﬁed in a yeast genetic screen
in search for factors that function in a survival pathway analogous to
that of human Bcl-xL [85]. Little evident similarity of SVF1 to known
mammalian genes is observed, but, however, it can partly be replaced
by human anti-apoptotic Bcl-xL [85,86]. Moreover, Svf1p facilitates
diauxic shift from glycolytic to oxidative metabolism in yeast, which
leads to enhanced levels of several anti-oxidant enzymes, including
Sod1p, Sod2p and glutathione synthase [87]. Svf1p also protects cells
against oxidative stress caused by lower growth temperature, which in
turn leads to the induction of anti-oxidant genes such as SOD1, GSH1
and CTT1 in the cell [86,88], whereas svf1 deletion mutants are more
sensitive towards oxidative stress caused by low growth tempera-
ture, exposure to chemical inducers or ROS precursors [86]. Together
these observations indicate that Svf1p's anti-apoptotic function is
most critical during rapid changes in environmental conditions when
protection against oxidative stress becomes necessary.Oxidative stress and increased intracellular ROS levels in yeast
can also be caused by an impairment of normal metabolic processes.
Recently, Lee et al. reported a relationship between the function of
Cit1p, the mitochondrial citrate synthase, and apoptosis [90]. Cit1p
catalyzes the ﬁrst step in the tricarboxylic cycle, the condensation of
acetyl-CoA and oxaloacetate to form citrate. A deletion mutant is
temperature sensitive [89] and unable to grow on acetate [90]. For its
ability to act properly, correct localization of Cit1p to themitochondria
is necessary [91]. The observed temperature sensitivity and acceler-
ated ageing of the cit1 deletion mutants has been shown to be due to
apoptosis, and consistently the cit1 deletion mutant exhibited higher
sensitivity to ROS-generating chemicals such as antimycin, rotenone,
H2O2, and acetic acid. These observations underline the importance of
an effective and well-regulated system that prevents ROS accumula-
tion, thereby protecting against apoptotic-like cell death.
Additional data highlighting the importance of an elaborate anti-
oxidant system has come from the opportunistic pathogen Candida
albicans. This organism inﬂicts with apoptosis in all kinds of mam-
malian cells and has itself been shown to undergo programmed cell
death when treated with acetic acid or H2O2 [92]. In C. albicans, a
disruption of GCS1, which encodes γ-glutamylcystein synthetase,
an essential enzyme in glutathione biosynthesis, leads to typical
hallmarks of apoptosis when the cells are depleted of glutathione and
γ-glutamylcysteine [93], indicating that tight regulation of intra-
cellular ROS is a general feature of the anti-apoptotic machinery in
eukaryotic organisms.
In conclusion, these results emphasize the importance of an
elaborate protective system against ROS consisting of a variety of
anti-oxidant enzymes such as superoxide dismutases, catalases and
enzymes for glutathione synthesis, that are responsible for the precise
regulation of intracellular ROS levels to prevent cells from undergoing
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well as alterations in stress response and metabolic pathways lead
to an increase of intracellular ROS and subsequent cell death.
5. Fis1p is a protein involved in mitochondrial ﬁssion that protects
against apoptosis
Fragmentation of mitochondria is an early event of apoptosis in
nematode and mammalian cells [94–97]. Accordingly, Fannjiang et al.
recently showed a link between the mitochondrial ﬁssion machinery
and apoptosis in yeast [11]. Fis1p is a highly conserved protein which
plays a role in ﬁssion of mitochondria in yeast and mammals, i.e. it
correctly distributes proteins required for ﬁssion within the outer
mitochondrial membrane, namely Dnm1p and Mdv1p [98–101].
However, Fis1p has also been shown to inhibit apoptosis in S. cerevisiae
as its deletion drastically enhances cell death in H2O2 treated cells in
an Yca1p-dependent manner [11]. The mechanism by which Fis1p
protects against apoptosis in S. cerevisiae remains unclear. However,
Fis1p, like the mammalian Bcl-2 and Bcl-xL proteins [99,102–105], is
anchored to the cytosolic side of the outer mitochondrial membrane
and shares some biophysical properties with these anti-apoptotic
proteins [11]. Moreover, the anti-apoptotic function of Fis1p can be
functionally replaced by either Bcl-2 or Bcl-xL, implying that Fis1p acts
in a Bcl-2-like manner [11].
6. Porin1 is a negative regulator of mitochondria-dependent
apoptosis in yeast
In the mitochondrial apoptotic pathway of mammals and yeast,
outer mitochondrial membrane permeabilization (MOMP) and the
release of pro-apoptotic proteins such as cytochrome c from the inter-
membrane space are crucial for programmed cell death. In mammals,
opening of a mitochondrial pore called permeability transition pore
(PTP) has been considered one of the key mechanisms underlying
MOMP [106]. Yet, the nature of the pore that releases these proteins is
still unknown and the identity of the proteins involved in its formation
is controversial [106–109]. However, yeast possesses homologues of
putative core PTP proteins like the yeast VDACs 1 and 2 (POR1 and 2),Fig. 4. Regulation of the apoptotic machinery in yeast. The key players and processes regu
eukaryotes, i.e. the inhibitor-of-apoptosis protein Bir1p, the caspase-like protein Yca1p an
mitochondria. Moreover, key regulators of mammalian apoptosis such as Bcl-2-like pro
interrelations, which have been hypothesized but yet not clearly demonstrated. Components
processes that protect against apoptosis are emphasized in red. PTP: permeability transitionthe yeast mitochondrial cyclophilin (CPR3) and three ADP/ATP carrier
proteins (AAC1, AAC2 and AAC3) that are believed to function in a
similar manner, forming a yeast PTP [110]. Pereira et al. analyzed the
role of these proteins in apoptosis and suggested that Por1p protects
against apoptosis [111], since a por1 deletion strain shows enhanced
apoptosis when treated with various death stimuli including acetic
acid, H2O2, or diamide, another oxidizing compound. In contrast,
deletion of CPR3 has no effect on cell death induced by any of these
stimuli. However, Liang et al. showed recently that deletion of CPR3
confers resistance to copper-induced apoptosis [112]. Furthermore the
loss of all three ADP/ATP carrier proteins leads to enhanced death
induced by H2O2, but confers protection against acetic acid [111].
Therefore Cpr3p as well as AAC proteins play different roles during cell
death depending on the death-triggering cellular context. Whether or
not the effects observed with the yeast strains lacking Por1p, Cpr3p
and the AAC proteins are due to their association with the yeast PTP
remains to be clariﬁed. As themammalian homologue of Por1p, VDAC,
is also localized to the plasma membrane, where it can regulate
apoptosis, Por1p might have functions in addition to those in the
mitochondrial outer membrane.
7. Cdc48p is directly or indirectly involved in apoptosis inhibition
Cdc48p, a protein encoded by the CDC48 gene, is essential for the
endoplasmic reticulum (ER)-associated protein degradation (ERAD) path-
way [113] and it participates in processes ensuring the integrity of the
ER and the nuclear envelope [114]. Cdc48p was the ﬁrst yeast protein
discovered to cause apoptotic-like cell death in S. cerevisiae if not fully
functional, suggesting that Cdc48p is able to inhibit apoptosis. In fact, the
human orthologue of Cdc48p, valosin-containing protein or VCP, has been
shown to be involved in apoptosis regulation in cultured cells [115,116].
Notably, several studies showed that elevated levels of VCP correlate with
increased incidences of metastasis in various types of cancer [117,118],
where cells show decreased ability to perform apoptosis.
When cellswith a cdc48 S565Gmutation are cultivatedunder different
growth conditions, they show typical hallmarks of apoptosis, such as
exposure of phosphatidylserine at the outer layer of the cytoplasmic
membrane, DNA single strand breaks, chromatin condensation andlating the basic molecular machinery of apoptosis are conserved from yeast to higher
d processes such as mitochondrial fragmentation and cytochrome c release from the
teins can interfere with the apoptotic machinery in yeast. Question marks indicate
of the putative PTP are highlighted in blue color (for details see Chapter 6). Proteins and
pore, MOMP: outer mitochondrial membrane permeabilization.
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subcellular fractions of wildtype and cdc48S565G mutant cells by two-
dimensional gel electrophoresis revealed that only minimal alterations
occur in the cytosolic fraction, whereas the mitochondrial fraction is
drastically affected by the mutation [82]. These proteomic alterations
lead to measurable mitochondrial dysfunction accompanied by release
of cytochrome c into the cytosol and mitochondrial swelling [82].
In yeast, mitochondrial respiration was shown to contribute to ROS
generation and cell death during ER stress caused by defects of the
unfolded protein response, UPR [119]. As ERAD is impaired in cdc48S565G
mutants [113], it is conceivable that mitochondrial impairment,
subsequent ROS accumulation and, ﬁnally, apoptosis observed in these
mutants are consequences of an ERAD dysfunction [82,120]. Even
though Cdc48p might not directly be involved in cell death inhibition,
the mutation causes defects that lead to an increase of intracellular ROS
followed by apoptosis. Thus, apoptosis probably occurs as a secondary
effect of the cdc48S565G mutation.
8. The translation elongation factor Ef2p plays a conserved role in
apoptosis inhibition
An important level onwhich regulation of apoptosis inhibition can
occur is by controlling translation, which became evident from stu-
dies in ﬁssion yeast. S. pombe was used as a model system to study
apoptosis induced by HIV-1 viral protein R (Vpr) [121]. Vpr induces
apoptosis in mammalian cells and is believed to contribute to CD4+
lymphocyte depletion, a hallmark of acquired immunodeﬁciency syn-
drome (AIDS) [122,123]. Heterologous expression of Vpr in ﬁssion
yeast leads to rapid cell death accompanied by some characteristics of
apoptotic cells [124,125]. In a genome-wide search for multicopy
suppressors of Vpr-induced apoptosis in S.pombe, EF2+ (elongation
factor 2) was identiﬁed as anti-apoptotic Vpr suppressor [121]. Over-
production of Ef2p in ﬁssion yeast as well as in human cells abolishes
Vpr-induced apoptosis [121]. The anti-apoptotic property of Ef2p in
human cells is demonstrated by its ability to suppress caspase 9 and
caspase 3-mediated apoptosis induced by Vpr [121]. Additionally, it
reduces cytochrome c release induced by Vpr, staurosporine and TNFα
[121]. Taken together these data suggest that Ef2p acts as a highly
conserved anti-apoptotic protein by a yet unknown molecular me-
chanism. However, Ef2p is an evolutionarily conserved monomeric
GTPase involved in protein synthesis and translation elongation and
its activity is regulated by several post-translational modiﬁcations
including phosphorylation and ribosylation [126], suggesting that Ef2p
may confer its anti-apoptotic effect through its regulatory role in
protein synthesis.
9. Conclusions and perspectives
Initially, yeast started out as a tool rather than as model organism
for apoptosis research. In recent years it has been established that
programmed cell death not only occurs in multicellular, but also in
unicellular yeasts. Different yeast species such as S. cerevisiae, S.
pombe, C. albicans, and Kluyveromyces lactis have been shown to
employ apoptotic-like death programs with typical hallmarks of
apoptosis and homologues of several metazoan apoptotic regulators
have been identiﬁed (for S. cerevisiae see Fig. 4).
Negative regulation of apoptosis in yeast can occur on multiple
cellular levels, in which the IAP Bir1p might play a central role. Bir1p
is able to protect yeast cells against cell death in response to H2O2
treatment and during chronological ageing. IAPs can inhibit caspase
activity either by direct binding via their BIR domains thereby pre-
venting caspase interaction with the substrate molecules or by remo-
ving caspases by targeting them for proteosomal degradation via their
RING domain. Bir1p, however, neither directly interacts with the yeast
caspase Yca1p nor does it contain a RING domain. Therefore, the
molecular mechanism by which Bir1p inhibits cell death remains tobe elucidated and will require the identiﬁcation of Bir1p targets that
might bridge the interaction to Yca1p and/or substitute for the func-
tion of the missing RING domain.
A second level of apoptosis inhibition in yeast occurs via a Bcl-2-
like pathway. Heterologous expression of mammalian pro-apopto-
tic Bcl-2-like proteins, such as Bax, causes apoptotic phenotypes in
yeast that is counteracted by simultaneous expression of anti-apop-
totic Bcl-2. Even though no Bcl-2-like proteins are known in yeast,
this observation implies the presence of an analogous pathway. In
this context, BI-1 and the prion protein as well as proteins that are
required to maintain mitochondrial integrity, such as Fis1p, might
play important roles.
Last, but not least, the precise regulation of ROS, which occur as a
byproduct of respiration and in response to environmental stresses, is
crucial for cell survival. Impairment of themachinery that is responsible
for regulating the levels of ROS within the cell, such as anti-oxidant
enzymes, glutathione, or regulators of actin dynamics, leads to apop-
tosis. Tight control of the anti-oxidant system is hence important for
protection against programmed cell death.
As yeast has become a convenient model organism for studying the
molecular mechanisms of programmed cell death, dissecting the mo-
lecular mechanisms underlying apoptosis inhibition in more detail in this
organism will eventually pave the way towards a better understanding
of similar metazoan pathways.
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